Sandoz, the global leader in affordable medicines, will host its 2026 capital markets day for investors and analysts. The formal part of the event will be webcast live starting at 13:30, with in-person attendance by invitation only. Additionally, Sandoz plans to host an investor and analyst site visit in Slovenia from 9 to 10 November, providing further insight into the company's new biosimilars development and supply-chain hub, though this event will not be webcast.
Sandoz Group AGHosting a capital markets day to present strategy for maximizing value in biosimilars, likely to attract investor interest and highlight growth prospects.